In HIV-1 infection, Vpu antagonizes tetherin-mediated restriction by downmodulating tetherin from the cell surface [15], [26]; compared to CD4+ T-cells, MDMs express higher endogenous tetherin levels than CD4+ T-cells [21], [23]. This evidence concerns the gene BST2 and HIV-1 infection.